TEThered to Runx

Novel binding partners for runx factors

Xiaodong Li, Matthew Decker, Jennifer J Westendorf

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

RUNX transcription factors reside in the nuclear matrix where they integrate numerous signaling pathways to regulate gene expression and affect tissue development, regeneration, and tumorigenesis. An affinity purification and proteomic experiment was performed to identify novel Runx2 binding partners. The interactions between Runx2 and two nuclear factors (Ddx5 and CoAA) identified in this screen were previously described. Coactivator activator (CoAA) bound the DNA binding domain of Runx2 and prevented Runx-driven gene expression. The YxxQ motif in CoAA was required for Runx2 interactions. Members of the FET/TET family of proteins, including FUS/TLS and EWSR1, contain a similar motif and were hypothesized to interact with Runx2. Here, we provide evidence that FUS/TLS, EWSR1, and the Ewing's sarcoma t(12;21) fusion protein EWS-FLI bind Runx2 and alter its transcriptional activity. Potential roles of protein complexes containing FET/TET and RUNX family members during tumor formation and mesenchymal progenitor cell differentiation are discussed.

Original languageEnglish (US)
Pages (from-to)82-85
Number of pages4
JournalBlood Cells, Molecules, and Diseases
Volume45
Issue number1
DOIs
StatePublished - Jun 2010

Fingerprint

RNA-Binding Protein FUS
Gene Expression
Nuclear Matrix
Ewing's Sarcoma
Mesenchymal Stromal Cells
Proteomics
Regeneration
Cell Differentiation
Carcinogenesis
Transcription Factors
DNA
Neoplasms
Proteins
EWS-FLI fusion protein

Keywords

  • CoAA
  • Ewing's sarcoma
  • EWS
  • EWS-FLI
  • FUS
  • TLS

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Molecular Medicine
  • Hematology

Cite this

TEThered to Runx : Novel binding partners for runx factors. / Li, Xiaodong; Decker, Matthew; Westendorf, Jennifer J.

In: Blood Cells, Molecules, and Diseases, Vol. 45, No. 1, 06.2010, p. 82-85.

Research output: Contribution to journalArticle

@article{78e3b5d5bd2344c1b65fd865566e1678,
title = "TEThered to Runx: Novel binding partners for runx factors",
abstract = "RUNX transcription factors reside in the nuclear matrix where they integrate numerous signaling pathways to regulate gene expression and affect tissue development, regeneration, and tumorigenesis. An affinity purification and proteomic experiment was performed to identify novel Runx2 binding partners. The interactions between Runx2 and two nuclear factors (Ddx5 and CoAA) identified in this screen were previously described. Coactivator activator (CoAA) bound the DNA binding domain of Runx2 and prevented Runx-driven gene expression. The YxxQ motif in CoAA was required for Runx2 interactions. Members of the FET/TET family of proteins, including FUS/TLS and EWSR1, contain a similar motif and were hypothesized to interact with Runx2. Here, we provide evidence that FUS/TLS, EWSR1, and the Ewing's sarcoma t(12;21) fusion protein EWS-FLI bind Runx2 and alter its transcriptional activity. Potential roles of protein complexes containing FET/TET and RUNX family members during tumor formation and mesenchymal progenitor cell differentiation are discussed.",
keywords = "CoAA, Ewing's sarcoma, EWS, EWS-FLI, FUS, TLS",
author = "Xiaodong Li and Matthew Decker and Westendorf, {Jennifer J}",
year = "2010",
month = "6",
doi = "10.1016/j.bcmd.2010.03.002",
language = "English (US)",
volume = "45",
pages = "82--85",
journal = "Blood Cells, Molecules, and Diseases",
issn = "1079-9796",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - TEThered to Runx

T2 - Novel binding partners for runx factors

AU - Li, Xiaodong

AU - Decker, Matthew

AU - Westendorf, Jennifer J

PY - 2010/6

Y1 - 2010/6

N2 - RUNX transcription factors reside in the nuclear matrix where they integrate numerous signaling pathways to regulate gene expression and affect tissue development, regeneration, and tumorigenesis. An affinity purification and proteomic experiment was performed to identify novel Runx2 binding partners. The interactions between Runx2 and two nuclear factors (Ddx5 and CoAA) identified in this screen were previously described. Coactivator activator (CoAA) bound the DNA binding domain of Runx2 and prevented Runx-driven gene expression. The YxxQ motif in CoAA was required for Runx2 interactions. Members of the FET/TET family of proteins, including FUS/TLS and EWSR1, contain a similar motif and were hypothesized to interact with Runx2. Here, we provide evidence that FUS/TLS, EWSR1, and the Ewing's sarcoma t(12;21) fusion protein EWS-FLI bind Runx2 and alter its transcriptional activity. Potential roles of protein complexes containing FET/TET and RUNX family members during tumor formation and mesenchymal progenitor cell differentiation are discussed.

AB - RUNX transcription factors reside in the nuclear matrix where they integrate numerous signaling pathways to regulate gene expression and affect tissue development, regeneration, and tumorigenesis. An affinity purification and proteomic experiment was performed to identify novel Runx2 binding partners. The interactions between Runx2 and two nuclear factors (Ddx5 and CoAA) identified in this screen were previously described. Coactivator activator (CoAA) bound the DNA binding domain of Runx2 and prevented Runx-driven gene expression. The YxxQ motif in CoAA was required for Runx2 interactions. Members of the FET/TET family of proteins, including FUS/TLS and EWSR1, contain a similar motif and were hypothesized to interact with Runx2. Here, we provide evidence that FUS/TLS, EWSR1, and the Ewing's sarcoma t(12;21) fusion protein EWS-FLI bind Runx2 and alter its transcriptional activity. Potential roles of protein complexes containing FET/TET and RUNX family members during tumor formation and mesenchymal progenitor cell differentiation are discussed.

KW - CoAA

KW - Ewing's sarcoma

KW - EWS

KW - EWS-FLI

KW - FUS

KW - TLS

UR - http://www.scopus.com/inward/record.url?scp=77953152916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953152916&partnerID=8YFLogxK

U2 - 10.1016/j.bcmd.2010.03.002

DO - 10.1016/j.bcmd.2010.03.002

M3 - Article

VL - 45

SP - 82

EP - 85

JO - Blood Cells, Molecules, and Diseases

JF - Blood Cells, Molecules, and Diseases

SN - 1079-9796

IS - 1

ER -